573 Results (Page 23 of 23)
France Markets Research Reports
France Constipation Therapeutics Market Analysis
France Constipation Therapeutics Market was valued at $501 Mn in 2022 and is estimated to reach $768 Mn in 2030, exhibiting a CAGR of 5.5% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Almirall, Boehringer Ingelheim, Ferring Pharmaceuticals, Ipsen Pharma, Johnson & Johnson, Norgine Pharmaceuticals, Pierre Fabre Médicament, Recordati and Sanofi.
France Herbal Supplements Market Report
The France Herbal Supplements Market was valued at $144.65 Mn in 2023 and is predicted to grow at a CAGR of 5.2% from 2023 to 2030, to $206.27 Mn by 2030. The key drivers of this industry include the growing popularity of healthy lifestyles, positive perception, and rising demand for immunity products. The industry is primarily dominated by players such as Herbalife, Botanic Supplements, Hishimo Pharmaceuticals Pvt. Ltd, and Weleda among others.
France Brain Cancer Therapeutics Market
France Brain Cancer Therapeutics Market valued at $63 Mn in 2022, projected to reach $132 Mn by 2030 with a 9.6% CAGR. The anticipated increase in brain cancer cases, particularly glioblastoma multiforme, is expected to be a key factor propelling the demand for brain cancer therapeutics, shaping the overall market landscape. Prominent players in the pharmaceutical sector currently operating are Roche, Merck & Co., Bristol Myers Squibb, Novartis, Pfizer, AstraZeneca, Eli Lilly, Sanofi, Takeda Pharmaceutical, and AbbVie.
France Brugada Syndrome Market Analysis
The France Brugada Syndrome Market was valued at $33 Mn in 2023 and is predicted to grow at a CAGR of 6.8% from 2023 to 2030, to $52.3 Mn by 2030. The key drivers of the market include growing prevalence of cardiovascular diseases, increased awareness and diagnosis, and technological innovations in treatment. The prominent players of the France Brugada Syndrome Market are Abbott Laboratories, Medtronic, Siemens Healthcare, Sanofi, and Abivax, among others.
France Clinical Nutrition for Chronic Kidney Diseases Market Analysis
France Clinical Nutrition for Chronic Kidney Diseases Market was valued at $43.20 Mn in 2023 and is predicted to grow at a CAGR of 5.03% from 2023 to 2030, to $60.90 Mn by 2030. The key drivers of this industry include rising CKD prevalence, aging populations, and technology advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
France Adult Malignant Glioma Therapeutics Market Analysis
The France Adult Glioma Therapeutics Market is valued at around $61 Mn in 2022 and is projected to reach $111 Mn by 2030, exhibiting a CAGR of 7.9% during the forecast period. The France Adult Malignant Glioma Therapeutics Market is predicted to develop gradually due to glioblastoma's poor prognosis, which drives the need for novel treatments, as well as rising incidence rates that contribute to market expansion. Key players in the France Adult Malignant Glioma Therapeutics Market include companies like Roche, Merck & Co., Novartis, Bayer, Kymab, Cellectis, Lysogene, AbbVie, Bristol-Myers Squibb, and Pfizer among others
France Blood Disorder Therapeutics Market
France Blood Disorder Therapeutics Market valued at $369 Mn in 2022, projected to reach $610 Mn by 2030 with a 6.5% CAGR. The key drivers of the market include greater disposable income among the French population, leading to an increased ability to afford expensive prescription drugs and specialized treatments for blood problems, and changes in the Western lifestyle causing a higher prevalence of the disease in the country. The France Market encompasses various players across different segments, including Takeda, Roche, Sanofi, Novartis, Novo Nordisk, CSL Ltd, Pfizer, LFB Biomedicaments, Walvax Biotech, Janssen-Cilag etc, among various others.
France Dental Endodontics Market Analysis
France Dental Endodontics Market was valued at $48.10 Mn in 2023 and is predicted to grow at a CAGR of 3.3% from 2023 to 2030, to $60.40 Mn by 2030. The key drivers of this industry include a growing focus on oral health awareness, an aging population, and technological advancement. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
France Clinical Nutrition Market Analysis
The France Clinical Nutrition Market was valued at $843.4 Mn in 2023 and is projected to grow at a CAGR of 4.34% from 2023 to 2023, to $11395.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Lactalis Health Nutrition, Laboratoires Gilbert, Abbott Nutrition, Pfizer Inc, Bayer AG, Nestle, Baxter International Inc, Ltd, Mead Johnson & Company, LLC among others.
France Breast Pump Market Report
The France Breast Pump Market was valued at $80.8 Mn in 2023 and is predicted to grow at a CAGR of 7.6% from 2023 to 2030, to $135 Mn by 2030. The key drivers of the market include the rising female workforce, technological advancements, and growing consumer awareness. The prominent players in the France Breast Pump Market are Spectra Baby, Playtex, Ameda, Avent, Evenflo, and Pigeon, among others.
France Cancer Induced Bone Disease Therapeutics Market
France Cancer Induced Bone Disease Therapeutics Market valued at $36 Mn in 2022, projected to reach $52 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increasing prevalence of different cancers, unmet medical needs of the population, and supportive government initiatives. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Johnson, and Bayer, among others.
France Digital Biomarkers Market Analysis
France Digital Biomarkers Market was valued at $79.75 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $308.15 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
France Congestive Heart Failure Therapeutics Market Analysis
The France Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $283 Mn in 2022 to $412 Mn by 2030, with a CAGR of 4.8% during the forecast period of 2022-2030. The key drivers in France include the aging population, contributing to an increased demand for CHF treatments, ongoing advancements in pharmaceutical research leading to innovative therapies, and government initiatives and reimbursement policies supporting accessibility. The France Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, Boehringer Ingelheim, Eli Lilly, Bayer, Merck, Servier, Amgen, Otsuka Pharmaceuticals, Lexicon Pharmaceuticals, Tenex Therapeutics, etc, among various others.
France Biosensors Market Analysis
The France Biosensors Market was valued at $794.8 Mn in 2023 and is predicted to grow at a CAGR of 7.0% from 2023 to 2030, to $1276.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, technological advancements, and growing demand for Point-of-Care (POC) testing. The prominent players of the France Biosensors Market are Villard Medical, Bio-Rad International, Masimo Corporation, Meridian Bioscience, and Biosensors International, among others.
France Medication Access Programs Market Analysis
The France Medication Access Programs Market was valued at $151 Mn in 2023 and is predicted to grow at a CAGR of 13.6% from 2023 to 2030, to $368.6 Mn by 2030. The key drivers of this industry include healthcare policies, increasing chronic diseases, and technological advancements. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
France Physiotherapy Equipment Market Analysis
The France Physiotherapy Equipment Market was valued at $574.75 Mn in 2023 and is predicted to grow at a CAGR of 6.2% from 2023 to 2030, to $875.69 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Kinvent Biomécanique SAS, Millet Innovation, SAS Physio Med, and Albatros France among others.
France Dental Consumables Market Analysis
The France Dental Consumables Market was valued at $929.5 Mn in 2023 and is projected to grow at a CAGR of 7.0% from 2023 to 2023, to $1492.6 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as Septodont, Pierre Fabre Oral Care, Dentsply Sirona, Henry Schein, Acteon Group, 3M, among others.
France Cardiac Arrhythmia Therapeutics Market
France Cardiac Arrhythmia Therapeutics Market valued at $198 Mn in 2022, projected to reach $288 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increasing prevalence of cardiac conditions, technological advancements, and the emerging therapeutics landscape. The industry is primarily dominated by players such as Abbott, Medtronic, Biotronik, Philips, GE, Nuubo, and Boston Scientific among others.
France LASIK Surgery Market Analysis
France LASIK Surgery Market was valued at $97.08 Mn in 2023 and is predicted to grow at a CAGR of 4.21% from 2023 to 2030, to $129.56 Mn by 2030. The key drivers of this industry include a high prevalence, strong economy, and technological advancements. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
France Medical Digital Imaging System Market Analysis
The France Medical Digital Imaging System Market was valued at $838.75 Mn in 2023 and is predicted to grow at a CAGR of 7.2% from 2023 to 2030, to $1364.57 Mn by 2030. The key drivers of this industry include an aging population, technological advancements, and government initiatives. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
France Breastfeeding Accessories Market Analysis
France Breastfeeding Accessories Market was valued at $69.03 Mn in 2023 and is predicted to grow at a CAGR of 5.80% from 2023 to 2030, to $102.43 Mn by 2030. The key drivers of this industry include rising employment rates for women, urbanization and lifestyle changes, and technological advancements. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.
France Chronic Pain Therapeutics Market Analysis
The France Chronic Pain Therapeutics Market is anticipated to experience a growth from $2.043 Bn in 2022 to $2.996 Bn by 2030, with a CAGR of 4.9% during the forecast period of 2022-2030. The key drivers include increased public awareness and early diagnosis, unmet medical needs prompting demand for innovative solutions, and technological advancements contributing to a more comprehensive and accessible landscape. The France Chronic Pain Therapeutics Market encompasses various players across different segments, including Sanofi, Pfizer, Johnson & Johnson, Novartis, Bayer, AstraZeneca, Merck, GSK, Ipsen, Pierre Fabre, etc., among various others.
France Hospital Market Analysis
The France Hospital Market was valued at $151.24 Bn in 2023 and is predicted to grow at a CAGR of 6.6% from 2023 to 2030, to $236.57 Bn by 2030. The key drivers of this industry are increase in incidences of chronic diseases, technological advancements, and rising healthcare spending. The key players in the industry are American Hospital of Paris, Geoffroy Saint Hilaire Clinic, Hôpital Privé Jean Mermoz, and Hôpital Lenval among others.